Breaking News Instant updates and real-time market news.

INTC

Intel

$44.49 /

-2.6 (-5.52%)

, AMD

AMD

$17.05 /

-1.775 (-9.43%)

06:51
01/04/19
01/04
06:51
01/04/19
06:51

BofA/Merrill prefers cloud and 5G exposure in semis, upgrades Intel to Buy

As previously reported, BofA Merrill Lynch analyst Vivek Arya upgraded Intel (INTC) to Buy from Neutral, stating that the stock provides attractive exposure to growth trends in cloud computing, AI, advanced autos and 5G. He forecasts total semiconductor industry sales to decelerate to down 3% year-over-year in 2019 and still expects enterprise, data center and parts of networking infrastructure to perform better than cyclical sectors such as industrial, automotive and smartphones, Arya tells investors. Risks, such as AMD (AMD) share loss, 7nm product delays, and tougher PC/data center comps, do exist, but now appear to be reflected in Intel shares, the analyst added. He raised his price target on Intel shares to $60 from $52.

INTC

Intel

$44.49 /

-2.6 (-5.52%)

AMD

AMD

$17.05 /

-1.775 (-9.43%)

  • 04

    Jan

  • 06

    Jan

  • 07

    Jan

  • 07

    Jan

  • 08

    Jan

  • 15

    Jan

  • 25

    Feb

INTC Intel
$44.49 /

-2.6 (-5.52%)

01/04/19 BofA
Intel upgraded to Buy from Neutral at BofA/Merrill
12/27/18 RBC Capital
Nvidia, AMD estimates lowered at RBC Capital on more cautious gaming view
12/18/18 Barclays
Cisco acquisition of Luxtera a negative for Macom, says Barclays
12/17/18 MKM Partners
Intel to be rewarded long-term for continued transformation, says MKM Partners
AMD AMD
$17.05 /

-1.775 (-9.43%)

12/21/18 Daiwa
AMD initiated with a Buy at Daiwa
12/20/18 BofA
BofA/Merrill sees prolonged weakness in GPUs, lowers AMD price target to $27
12/19/18 Susquehanna
Susquehanna sees Mellanox as top Semiconductors M&A target for 2019

TODAY'S FREE FLY STORIES

Upgrade
Harvey Norman upgraded to Buy from Neutral at Goldman Sachs » 04:53
09/21/21
09/21
04:53
09/21/21
04:53
HNORY

Harvey Norman

$21.41 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HNORY Harvey Norman
$21.41 /

+ (+0.00%)

02/28/21 Goldman Sachs
Harvey Norman downgraded to Neutral from Buy at Goldman Sachs
02/23/21 Credit Suisse
Harvey Norman downgraded to Neutral from Outperform at Credit Suisse
Initiation
FinVolution Group initiated with a Buy at China Renaissance » 04:50
09/21/21
09/21
04:50
09/21/21
04:50
FINV

FinVolution Group

$5.55 /

-0.255 (-4.39%)

China Renaissance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

08/24/21 Citi
FinVolution Group downgraded to Neutral from Buy at Citi
03/12/21 Citi
FinVolution Group upgraded to Buy from Neutral at Citi
FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

Recommendations
Zenvia price target lowered to $30.50 from $35 at Goldman Sachs » 04:50
09/21/21
09/21
04:50
09/21/21
04:50
ZENV

Zenvia

$16.05 /

-0.03 (-0.19%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZENV Zenvia
$16.05 /

-0.03 (-0.19%)

08/23/21 Itau BBA
Zenvia initiated with an Outperform at Itau BBA
08/16/21 Morgan Stanley
Morgan Stanley starts Zenvia at Overweight, sees 'clear path toward re-rating'
08/16/21 Morgan Stanley
Zenvia initiated with an Overweight at Morgan Stanley
08/16/21 Goldman Sachs
Zenvia initiated with a Buy at Goldman Sachs
  • 22
    Jul
ZENV Zenvia
$16.05 /

-0.03 (-0.19%)

Upgrade
Atento upgraded to Neutral from Sell at Goldman Sachs » 04:48
09/21/21
09/21
04:48
09/21/21
04:48
ATTO

Atento

$28.98 /

-0.42 (-1.43%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATTO Atento
$28.98 /

-0.42 (-1.43%)

ATTO Atento
$28.98 /

-0.42 (-1.43%)

03/05/21 Barrington
Atento price target raised to $25 from $20 at Barrington
ATTO Atento
$28.98 /

-0.42 (-1.43%)

Upgrade
Globant upgraded to Buy from Neutral at Goldman Sachs » 04:46
09/21/21
09/21
04:46
09/21/21
04:46
GLOB

Globant

$313.11 /

-6.91 (-2.16%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOB Globant
$313.11 /

-6.91 (-2.16%)

GLOB Globant
$313.11 /

-6.91 (-2.16%)

08/26/21 Jefferies
Globant price target raised to $371 from $290 at Jefferies
08/17/21 JPMorgan
Globant price target raised to $340 from $284 at JPMorgan
08/13/21 Cowen
Globant price target raised to $290 from $260 at Cowen
08/03/21
Fly Intel: Top five analyst upgrades
GLOB Globant
$313.11 /

-6.91 (-2.16%)

  • 26
    May
GLOB Globant
$313.11 /

-6.91 (-2.16%)

Downgrade
Zumiez downgraded to Hold from Buy at Jefferies » 04:44
09/21/21
09/21
04:44
09/21/21
04:44
ZUMZ

Zumiez

$40.89 /

-1.75 (-4.10%)

Jefferies analyst Janine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

09/13/21 B. Riley
Zumiez price target lowered to $56 from $65 at B. Riley
09/10/21 Baird
Zumiez price target lowered to $47 from $52 at Baird
09/08/21 Pivotal Research
Zumiez price target lowered to $45 from $52 at Pivotal Research
06/04/21 B. Riley
Zumiez price target raised to $65 from $55 at B. Riley
ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

Upgrade
Steven Madden upgraded to Buy from Hold at Jefferies » 04:43
09/21/21
09/21
04:43
09/21/21
04:43
SHOO

Steven Madden

$39.18 /

-0.49 (-1.24%)

Jefferies analyst Janine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

09/17/21 BTIG
Steven Madden price target raised to $59 from $57 at BTIG
07/29/21 B. Riley
Steven Madden price target raised to $51 from $50 at B. Riley
07/29/21 Piper Sandler
Steven Madden price target raised to $45 from $39 at Piper Sandler
06/17/21 B. Riley
Steven Madden price target raised to $50 from $46 at B. Riley
SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

Downgrade
Oshkosh downgraded to Hold from Buy at Jefferies » 04:42
09/21/21
09/21
04:42
09/21/21
04:42
OSK

Oshkosh

$107.06 /

-1.1451 (-1.06%)

Jefferies analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSK Oshkosh
$107.06 /

-1.1451 (-1.06%)

OSK Oshkosh
$107.06 /

-1.1451 (-1.06%)

08/30/21 Baird
Machinery stock pullback brings buying opportunities, says Baird
08/24/21
Fly Intel: Top five analyst downgrades
08/24/21 Goldman Sachs
Oshkosh downgraded to Buy from Conviction Buy at Goldman Sachs
07/14/21 Deutsche Bank
Oshkosh named 'Catalyst Call: Buy Idea' at Deutsche Bank
OSK Oshkosh
$107.06 /

-1.1451 (-1.06%)

OSK Oshkosh
$107.06 /

-1.1451 (-1.06%)

OSK Oshkosh
$107.06 /

-1.1451 (-1.06%)

Upgrade
Svenska Cellulosa upgraded to Buy from Hold at Jefferies » 04:41
09/21/21
09/21
04:41
09/21/21
04:41
SVCBF

Svenska Cellulosa

$15.78 /

+ (+0.00%)

Jefferies analyst Cole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SVCBF Svenska Cellulosa
$15.78 /

+ (+0.00%)

09/13/21 Danske Bank
Svenska Cellulosa downgraded to Sell from Hold at Danske Bank
07/14/21 Kepler Cheuvreux
Svenska Cellulosa upgraded to Hold from Reduce at Kepler Cheuvreux
07/09/21 Pareto
Svenska Cellulosa upgraded to Hold from Sell at Pareto
05/25/21 Danske Bank
Svenska Cellulosa downgraded to Hold from Buy at Danske Bank
General news
FX Action: USD-JPY is higher » 04:25
09/21/21
09/21
04:25
09/21/21
04:25
$ECON

Economic Data

/

+

FX Action: USD-JPY is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
European stock markets are broadly higher » 03:35
09/21/21
09/21
03:35
09/21/21
03:35
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
The FOMC is front and center this week » 02:10
09/21/21
09/21
02:10
09/21/21
02:10
$ECON

Economic Data

/

+

The FOMC is front and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. current account preview » 02:00
09/21/21
09/21
02:00
09/21/21
02:00
$ECON

Economic Data

/

+

U.S. current account…

U.S. current account preview: the deficit is expected to narrow to -$189.9 B in Q2 after widening to a 15-year high of -$195.7 B in Q1. Analysts saw a -$208.4 B goods and services trade deficit in Q2. As a percentage of nominal GDP, the gap is expected to sit at -3.3% in Q2, down from -3.6%. Analysts saw Q2 growth for goods, services, and income of 26.6% for exports and 20.6% for imports, as global trade in goods and services continues to rebound from the COVID-19 hit. Analysts expect an annual current account deficit of -$740 B in 2021, versus a high from the last expansion of -$480 B in 2019. The deficit is sitting near to the -$806 B record gap back in 2006.

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. housing starts preview » 02:00
09/21/21
09/21
02:00
09/21/21
02:00
$ECON

Economic Data

/

+

U.S. housing starts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Gossamer Bio assumed with an Overweight at Piper Sandler » 21:25
09/20/21
09/20
21:25
09/20/21
21:25
GOSS

Gossamer Bio

$10.26 /

-0.29 (-2.75%)

Piper Sandler analyst…

Piper Sandler analyst Yasmeen Rahimi assumed coverage of Gossamer Bio with an Overweight rating and $26 price target. The analyst has "strong conviction" on both the company's clinical stage assets: Seralutinib for pulmonary arterial hypertension and GB004 for ulcerative colitis. The analyst is positive on the shares into the two second half of 2021 data readouts.

ShowHide Related Items >><<
GOSS Gossamer Bio
$10.26 /

-0.29 (-2.75%)

GOSS Gossamer Bio
$10.26 /

-0.29 (-2.75%)

03/24/21 H.C. Wainwright
Gossamer Bio price target raised to $25 from $24 at H.C. Wainwright
12/17/20 H.C. Wainwright
Gossamer Bio price target raised to $24 from $15 at H.C. Wainwright
10/19/20 H.C. Wainwright
Gossamer Bio price target lowered to $15 from $31 at H.C. Wainwright
10/16/20 Barclays
Gossamer Bio price target lowered to $18 from $22 at Barclays
GOSS Gossamer Bio
$10.26 /

-0.29 (-2.75%)

  • 30
    Oct
Hot Stocks
Designer Brands executive chairman buys 1.49M share of common stock » 21:05
09/20/21
09/20
21:05
09/20/21
21:05
DBI

Designer Brands

$13.26 /

+0.405 (+3.15%)

In a regulatory filing,…

In a regulatory filing, Designer Brands disclosed that its executive chairman Jay Schottenstein bought 1.496M shares of common stock on September 16th in a total transaction size of $19.1M, boosting his stake by about 47%.

ShowHide Related Items >><<
DBI Designer Brands
$13.26 /

+0.405 (+3.15%)

DBI Designer Brands
$13.26 /

+0.405 (+3.15%)

09/01/21 Deutsche Bank
Designer Brands price target raised to $19 from $18 at Deutsche Bank
03/17/21 Deutsche Bank
Designer Brands price target raised to $14 from $12 at Deutsche Bank
01/21/21 Deutsche Bank
Designer Brands price target raised to $12 from $7 at Deutsche Bank
01/08/21 CL King
Designer Brands named a top pick for 2021 at CL King
DBI Designer Brands
$13.26 /

+0.405 (+3.15%)

DBI Designer Brands
$13.26 /

+0.405 (+3.15%)

Hot Stocks
Medical Properties Trust enters into 15-year master lease with HCA Healthcare » 20:58
09/20/21
09/20
20:58
09/20/21
20:58
MPW

Medical Properties Trust

$20.19 /

+0.14 (+0.70%)

, HCA

HCA Healthcare

$254.98 /

-3.78 (-1.46%)

Medical Properties Trust…

Medical Properties Trust (MPW) "announced that it has entered into an agreement to lease substantially all of its Utah hospitals to HCA Healthcare (HCA), following an agreement by HCA Healthcare to purchase the operations of five Utah facilities from Steward Health Care System, for which the financial terms of the sale will remain confidential. MPT's purchase price of $1.2B for the Utah hospitals represents approximately 5.0% of the company's total pro forma gross assets, which will place HCA Healthcare among the five largest tenants in the MPT portfolio. Following completion of this agreement with HCA Healthcare and closing of other recently announced transactions, the percentage of MPT's portfolio represented by Steward assets is expected to decrease to approximately 17%."

ShowHide Related Items >><<
MPW Medical Properties Trust
$20.19 /

+0.14 (+0.70%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

MPW Medical Properties Trust
$20.19 /

+0.14 (+0.70%)

08/11/21 RBC Capital
Medical Properties Trust upgraded to Outperform at RBC Capital on valuation
08/11/21 RBC Capital
Medical Properties Trust upgraded to Outperform from Sector Perform at RBC Capital
07/14/21 Mizuho
Medical Properties Trust assumed with a Buy at Mizuho
07/06/21 BofA
Medical Properties downgraded to Neutral on funding needs at BofA
HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

09/09/21 Cowen
HCA's EBITDA outperformance remains underestimated, says Cowen
09/09/21 Cowen
HCA Healthcare initiated with an Outperform at Cowen
08/12/21 Barclays
HCA Healthcare assumed at Equal Weight from Overweight at Barclays
07/22/21 Barclays
HCA Healthcare price target raised to $275 from $225 at Barclays
MPW Medical Properties Trust
$20.19 /

+0.14 (+0.70%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

  • 07
    Jan
MPW Medical Properties Trust
$20.19 /

+0.14 (+0.70%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

MPW Medical Properties Trust
$20.19 /

+0.14 (+0.70%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

Recommendations
Herc Holdings price target raised to $158 from $145 at Baird » 20:41
09/20/21
09/20
20:41
09/20/21
20:41
HRI

Herc Holdings

$125.41 /

-4.1 (-3.17%)

Baird analyst Mircea…

Baird analyst Mircea Dobre raised the firm's price target on Herc Holdings to $158 from $145 and keeps an Outperform rating on the shares. The analyst cites the company's guidance raise and the management's "robust" three-year growth plan.

ShowHide Related Items >><<
HRI Herc Holdings
$125.41 /

-4.1 (-3.17%)

HRI Herc Holdings
$125.41 /

-4.1 (-3.17%)

09/16/21 Baird
Ashtead results positive for United Rentals and Herc, says Baird
07/23/21 Barclays
Herc Holdings price target raised to $135 from $128 at Barclays
07/22/21 Baird
Herc Holdings price target raised to $145 from $135 at Baird
07/14/21 Barclays
Herc Holdings price target raised to $128 from $115 at Barclays
HRI Herc Holdings
$125.41 /

-4.1 (-3.17%)

HRI Herc Holdings
$125.41 /

-4.1 (-3.17%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
09/20/21
09/20
20:25
09/20/21
20:25
AZO

AutoZone

$1,588.97 /

-6.68 (-0.42%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include AutoZone (AZO), consensus $29.87.

ShowHide Related Items >><<
AZO AutoZone
$1,588.97 /

-6.68 (-0.42%)

AZO AutoZone
$1,588.97 /

-6.68 (-0.42%)

09/13/21 DA Davidson
AutoZone downgraded to Neutral from Buy at DA Davidson
08/27/21
Fly Intel: Top five analyst downgrades
08/27/21 Morgan Stanley
AutoZone downgraded to Equal Weight from Overweight at Morgan Stanley
08/27/21 Morgan Stanley
AutoZone downgraded to Equal Weight from Overweight at Morgan Stanley
AZO AutoZone
$1,588.97 /

-6.68 (-0.42%)

AZO AutoZone
$1,588.97 /

-6.68 (-0.42%)

Conference/Events
Morgan Stanley Asian gaming analyst to hold analyst/industry conference call » 20:15
09/20/21
09/20
20:15
09/20/21
20:15

Asiam Gaming &…

Asiam Gaming & Lodging Analyst Choudhary, along with Former Senior Legal Adviser to Macau, Antonie Lobo Vilela, discuss navigating the gaming law revision and concession renewal process on an Analyst/Industry conference call to be held on September 20 at 8:30 pm.

Hot Stocks
Hutchmed initiates Surtori-01 phase 3 trial of Sulanda in NEC » 20:02
09/20/21
09/20
20:02
09/20/21
20:02
HCM

Hutchmed

$38.24 /

-0.64 (-1.65%)

Hutchmed Limited…

Hutchmed Limited announces that it has initiated SURTORI-01, a Phase III study to evaluate the efficacy and safety of surufatinib in combination with toripalimab compared with FOLFIRI to treat patients with advanced neuroendocrine carcinoma, or NEC, who have progression of disease or intolerable toxicity after previous first-line chemotherapy. The first patient was dosed on September 18, 2021 in China. Toripalimab is marketed as TUOYI in China by Shanghai Junshi Biosciences Co., Ltd.

ShowHide Related Items >><<
HCM Hutchmed
$38.24 /

-0.64 (-1.65%)

HCM Hutchmed
$38.24 /

-0.64 (-1.65%)

08/03/21 Jefferies
Hutchmed initiated with a Buy at Jefferies
07/13/21 Cantor Fitzgerald
Hutchmed price target raised to $45 from $40 at Cantor Fitzgerald
10/02/20 Deutsche Bank
Hutchison China MediTech initiated with a Buy at Deutsche Bank
HCM Hutchmed
$38.24 /

-0.64 (-1.65%)

HCM Hutchmed
$38.24 /

-0.64 (-1.65%)

Hot Stocks
HCA Healthcare to buy five Utah hospitals from Steward Health Care » 19:46
09/20/21
09/20
19:46
09/20/21
19:46
HCA

HCA Healthcare

$254.98 /

-3.78 (-1.46%)

HCA Healthcare and…

HCA Healthcare and Steward Health Care announced the signing of a definitive agreement for HCA Healthcare to acquire the operations of Steward Health Care's five Utah hospitals. HCA Healthcare also entered into an agreement to lease the related real estate from its owner following the expected closing. The hospitals will become part of HCA Healthcare's Mountain Division, which includes 11 hospitals in Utah, Idaho and Alaska.

ShowHide Related Items >><<
HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

09/09/21 Cowen
HCA's EBITDA outperformance remains underestimated, says Cowen
09/09/21 Cowen
HCA Healthcare initiated with an Outperform at Cowen
08/12/21 Barclays
HCA Healthcare assumed at Equal Weight from Overweight at Barclays
07/22/21 Barclays
HCA Healthcare price target raised to $275 from $225 at Barclays
HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

HCA HCA Healthcare
$254.98 /

-3.78 (-1.46%)

Hot Stocks
Equity Bancshares initiates 8c per share quarterly dividend » 19:18
09/20/21
09/20
19:18
09/20/21
19:18
EQBK

Equity Bancshares

$30.43 /

+0.11 (+0.36%)

The dividend is payable…

The dividend is payable on October 14, 2021 to stockholders of record at the close of business on September 30, 2021.

ShowHide Related Items >><<
EQBK Equity Bancshares
$30.43 /

+0.11 (+0.36%)

EQBK Equity Bancshares
$30.43 /

+0.11 (+0.36%)

Initiation
CapitaLand initiated with a Buy at Goldman Sachs » 19:16
09/20/21
09/20
19:16
09/20/21
19:16
CLLDY

CapitaLand

$5.73 /

-0.06 (-1.04%)

Goldman Sachs analyst…

Goldman Sachs analyst Xuan Tan initiated coverage of CapitaLand with a Buy rating and S$3.64 price target. The company has sharpened its focus as a real estate investment manager with the privatization of its development segment, the analyst tells investors in a research note. Xuan Tan sees benefits of the restructuring coming in the form of improved earnings visibility and margins.

ShowHide Related Items >><<
CLLDY CapitaLand
$5.73 /

-0.06 (-1.04%)

03/23/21 Goldman Sachs
CapitaLand initiated with a Buy at Goldman Sachs
Initiation
Rathbone Brothers initiated with an Overweight at Barclays » 19:12
09/20/21
09/20
19:12
09/20/21
19:12
RTBBF

Rathbone Brothers

$20.35 /

+ (+0.00%)

Barclays analyst Alex…

Barclays analyst Alex Medhurst initiated coverage of Rathbone Brothers with an Overweight rating and 2,500 GBp price target. The analyst believes that the stock trading below its average multiple is at odds with an improving growth outlook; the Saunderson House transaction addressing past concerns over a lack of scale and growth in financial planning; and a material gearing to positive trends in ESG investing.

ShowHide Related Items >><<
RTBBF Rathbone Brothers
$20.35 /

+ (+0.00%)

11/18/20 Berenberg
Rathbone Brothers upgraded to Buy from Hold at Berenberg

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.